Draft. MD Anderson Cancer Network 2013 Education Videoconference Schedule. Topic Date Faculty Case Information Due. Holiday New Year's Day 1/1/2013

Size: px
Start display at page:

Download "Draft. MD Anderson Cancer Network 2013 Education Videoconference Schedule. Topic Date Faculty Case Information Due. Holiday New Year's Day 1/1/2013"

Transcription

1 Draft MD Anderson Cancer Network 2013 Holiday New Year's Day 1/1/2013 MPC Breast 1/8/2013 Gildy Babiera, MD 1/3/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD MPC Colorectal/ Gastric 1/15/2013 Thomas Aloia, MD 1/10/2013 Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology Holiday Martin Luther King Day 1/21/2013 Page 1

2 MPC Bladder/ Kidney 1/29/2013 Ana Aparicio, MD 1/24/2013 Prostate/ Testicular Assistant Professor, Genitourinary Medical Oncology John Davis, MD Assistant Professor, Urology Deborah Kuban, MD Professor, Radiation Oncology Radiaton Oncology Advanced Breast 2/5/2013 Benjamin Smith, MD Education Presentation Cancer Cases Welela Tereffe, MD MPC Head & Neck 2/12/2013 Amy Hessel, MD 2/7/2013 Thoracic/ Esophageal Associate Professor, Head & Neck Surgery Steven Frank, MD Ara Vaporciyan, MD Professor, Thoracic & Cardiovascular Surgery William William, MD Assistant Professor, Thoracic/ Head & Neck Medical Oncology Alexandria Phan, MD Associate Professor, GI Medical Oncology Steven Lin, MD Page 2

3 MPC Leukemia/ Lymphoma 2/19/2013 Bouthaina Dabaja, MD 2/14/2013 Myeloma Stefan Faderl, MD Professor, Leukemia Sheeba Thomas, MD Assistant Professor, Myeloma Francesco Turturro, MD Professor, Lymphoma Speaker's Bureau Hormone Therapy and 2/26/2013 Ana Aparicia, MD Castrate Resistant Prostate Cancer Assistant Professor, Genitourinary Medical Oncology MPC Breast 3/5/2013 Gildy Babiera, MD 2/18/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD Speaker's Bureau Cancer Genetics 3/13/2013 Banu Arun, MD Wednesday Professor, Breast Medical Oncology 12PM 1PM Co Medical Director Clincal Cancer Genetics Page 3

4 MPC Colorectal/ Gastric 3/19/2013 Thomas Aloia, MD 3/14/2013 Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology MPC Bladder/ Kidney 3/26/2013 Ana Aparicio, MD 3/21/2013 Prostate/ Testicular Assistant Professor, Genitourinary Medical Oncology John Davis, MD Assistant Professor, Urology Deborah Kuban, MD Professor, Radiation Oncology Speaker's Bureau Tissue Banking 4/9/2013 Diana Bell, MD Assistant Professor, Pathology Page 4

5 MPC Leukemia/ Lymphoma 4/16/2013 Bouthaina Dabaja, MD 4/11/2013 Myeloma Stefan Faderl, MD Professor, Leukemia Sheeba Thomas, MD Assistant Professor, Myeloma Francesco Turturro, MD Professor, Lymphoma MPC Head & Neck 4/23/2013 Amy Hessel, MD 4/18/2013 Thoracic/ Esophageal Associate Professor, Head & Neck Surgery Steven Frank, MD Ara Vaporciyan, MD Professor, Thoracic & Cardiovascular Surgery William William, MD Assistant Professor, Thoracic/ Head & Neck Medical Oncology Alexandria Phan, MD Associate Professor, GI Medical Oncology Steven Lin, MD Page 5

6 MPC Breast 4/30/2013 Gildy Babiera, MD 4/25/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD MPC Colorectal/ Gastric 5/7/2013 Thomas Aloia, MD 5/2/2013 Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology MPC Bladder/ Kidney 5/14/2013 Ana Aparicio, MD 5/9/2013 Prostate/ Testicular Assistant Professor, Genitourinary Medical Oncology John Davis, MD Assistant Professor, Urology Deborah Kuban, MD Professor, Radiation Oncology Page 6

7 Holiday Memorial Day 5/28/2013 Speaker's Bureau TBD 6/4/2013 MPC Leukemia/ Lymphoma 6/11/2013 Bouthaina Dabaja, MD 6/6/2013 Myeloma Stefan Faderl, MD Professor, Leukemia Sheeba Thomas, MD Assistant Professor, Myeloma Francesco Turturro, MD Professor, Lymphoma MPC Breast 6/18/2013 Gildy Babiera, MD 6/13/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD Page 7

8 MPC Colorectal/ Gastric 6/25/2013 Thomas Aloia, MD 6/20/2013 Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology MPC Head & Neck 7/2/2013 Amy Hessel, MD 6/27/2013 Thoracic/ Esophageal Associate Professor, Head & Neck Surgery Steven Frank, MD Ara Vaporciyan, MD Professor, Thoracic & Cardiovascular Surgery William William, MD Assistant Professor, Thoracic/ Head & Neck Medical Oncology Alexandria Phan, MD Associate Professor, GI Medical Oncology Steven Lin, MD Page 8

9 MPC Bladder/ Kidney 7/9/2013 Ana Aparicio, MD 7/3/2013 Prostate/ Testicular Assistant Professor, Genitourinary Medical Oncology John Davis, MD Assistant Professor, Urology Deborah Kuban, MD Professor, Radiation Oncology MPC Leukemia/ Lymphoma 7/23/2013 Bouthaina Dabaja, MD 7/18/2013 Myeloma Stefan Faderl, MD Professor, Leukemia Sheeba Thomas, MD Assistant Professor, Myeloma Francesco Turturro, MD Professor, Lymphoma MD Anderson Cancer Center and MD Anderson July 27 30, 2013 Physicians Network Cancer Symposium The Peabody Hotel, Orlando, FL Page 9

10 MPC Breast 8/6/2013 Gildy Babiera, MD 8/1/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD MPC Colorectal/Gastric 8/13/2013 Thomas Aloia, MD 8/8/2013 Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology Speaker's Bureau TBD 8/20/2013 Speaker's Bureau TBD 8/27/2013 Holiday Labor Day 9/2/2013 Page 10

11 MPC Bladder/ Kidney 9/10/2013 Ana Aparicio, MD 9/5/2013 Prostate/ Testicular Assistant Professor, Genitourinary Medical Oncology John Davis, MD Assistant Professor, Urology Deborah Kuban, MD Professor, Radiation Oncology MPC Head & Neck 9/17/2013 Amy Hessel, MD 9/12/2013 Thoracic/ Esophageal Associate Professor, Head & Neck Surgery Steven Frank, MD Ara Vaporciyan, MD Professor, Thoracic & Cardiovascular Surgery William William, MD Assistant Professor, Thoracic/ Head & Neck Medical Oncology Alexandria Phan, MD Associate Professor, GI Medical Oncology Steven Lin, MD Page 11

12 MPC Breast 10/1/2013 Gildy Babiera, MD 9/26/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD Speaker's Bureau TBD 10/8/2013 MPC Colorectal/ Gastric 10/15/2013 Thomas Aloia, MD 10/10/2013 Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology Page 12

13 MPC Leukemia/ Lymphoma 10/22/2013 Bouthaina Dabaja, MD 10/17/2013 Myeloma Stefan Faderl, MD Professor, Leukemia Sheeba Thomas, MD Assistant Professor, Myeloma Francesco Turturro, MD Professor, Lymphoma Speaker's Bureau TBD 10/29/2013 MPC Bladder/ Kidney 11/5/2013 Ana Aparicio, MD 10/31/2013 Prostate/ Testicular Assistant Professor, Genitourinary Medical Oncology John Davis, MD Assistant Professor, Urology Deborah Kuban, MD Professor, Radiation Oncology MPC Breast 11/12/2013 Gildy Babiera, MD 11/7/2013 Associate Professor, Surgical Oncology Jennifer Litton, MD Assistant Professor, Medical Oncology Benjamin Smith, MD Page 13

14 MPC 11/14/2013 Colorectal/ Gastric 11/19/2013 Thomas Aloia, MD Liver/ Pancreas Assistant Professor, Surgical Oncology Miguel Rodriguez Bigas, MD Professor, Surgical Oncology Prajnan Das, MD Christopher Garrett, MD Associate Professor, Medical Oncology Holiday Thanksgiving 11/28/2012 MPC 12/5/2013 Leukemia/ Lymphoma 12/3/2013 Bouthaina Dabaja, MD Myeloma Stefan Faderl, MD Professor, Leukemia Sheeba Thomas, MD Assistant Professor, Myeloma Francesco Turturro, MD Professor, Lymphoma Page 14

15 MPC Head & Neck 12/10/2013 Amy Hessel, MD 12/12/2013 Thoracic/ Esophageal Associate Professor, Head & Neck Surgery Steven Frank, MD Ara Vaporciyan, MD Professor, Thoracic & Cardiovascular Surgery William William, MD Assistant Professor, Thoracic/ Head & Neck Medical Oncology Alexandria Phan, MD Associate Professor, GI Medical Oncology Steven Lin, MD Holiday Christmas 12/25/2013 Page 15

16 Page 16

17 Page 17

18 Page 18

19 Page 19

20 Page 20

21 Page 21

22 ` Page 22

MDAPN 2016 Education Videoconference Schedule. Topic Date Faculty. No MPC 1/5/2016 Happy New Year

MDAPN 2016 Education Videoconference Schedule. Topic Date Faculty. No MPC 1/5/2016 Happy New Year MDAPN 2016 Education Videoconference Schedule Topic Date Faculty No MPC 1/5/2016 Happy New Year Breast 1/12/2016 Gildy Babiera, MD ** CME Evaluation** No MPC 1/19/2016 Martin Luther King Holiday Head &

More information

Assistant Professor, GI Medical Oncology Updates in the Management of Colorectal Cancer

Assistant Professor, GI Medical Oncology Updates in the Management of Colorectal Cancer Fiscal Year 2019 Multidisciplinary Planning Conference and Speaker Bureau Schedule For Central/Eastern Time Zone Cancer Network Members Tuesdays 7:00-8:00 AM CT 8:00-9:00 AM ET Topic Date Labor Day 9/3/18

More information

PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018

PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, Steamboat Springs, Colorado. January 12-15, 2018 PLEASE NOTE THE PROGRAM BEGINS ON FRIDAY MORNING, JANUARY 12, 2018 16 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 12-15, 2018 Friday, January 12, 2018 Registration:

More information

Steamboat Springs, Colorado. January 15-18, 2016

Steamboat Springs, Colorado. January 15-18, 2016 Friday, January 15, 2016 Registration: Begins at 2:00 pm Plenary Session: 4:00 pm - 6:00 pm 14 th Oncology Update: Advances and Controversies Steamboat Springs, Colorado January 15-18, 2016 Current Status

More information

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,

More information

Cancer prevalence. Chapter 7

Cancer prevalence. Chapter 7 Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.

More information

Phase-specific Costs of Cancer Care in Ontario

Phase-specific Costs of Cancer Care in Ontario Phase-specific Costs of Cancer Care in Ontario Canadian Association of Health Services and Policy Research Conference Session: D5 Cancer Care Wednesday May 29 2013 Claire de Oliveira, M.A. PhD Background

More information

Supplemental Table 1.1: Prostate cancer prognostic tools

Supplemental Table 1.1: Prostate cancer prognostic tools Supplemental Table 1.1: Prostate cancer prognostic tools Features ANN^ BioChemical Capra^ CSQS EBRT Han Outcomes Cancer Specific - - +* + - - Non-Cancer Specific - - - + - - DFS/PFS +* +* +* - +* +* Clinical

More information

Independent Medical Education Grants Published October 2018

Independent Medical Education Grants Published October 2018 Academy for Continued Healthcare Learning Faculty Rounds: Exploring the Advances in the Management of Invasive Fungal Infections $99,580.00 American Association for Cancer Research AACR Cancer Health Disparities

More information

Page 1 of 8 TABLE OF CONTENTS

Page 1 of 8 TABLE OF CONTENTS Page 1 of 8 TABLE OF CONTENTS Patient Evaluation and Recommendation..Page 2 Testing and Follow-up..Page 3 Genetic Counseling Referral Criteria.....Page 4-5 Patient Education..Page 6 Suggested Readings...Page

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.

More information

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 19-21, 2016 Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 19-21, 2016 Wednesday, October 19, 2016 7:30 8:30 AM Registration

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited

More information

Colorectal Cancer Screening

Colorectal Cancer Screening Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program

More information

DEPARTMENT OF ONCOLOGY ELECTIVE

DEPARTMENT OF ONCOLOGY ELECTIVE DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:

More information

2016 Oncology Institute Annual Report

2016 Oncology Institute Annual Report 2016 Oncology Institute Annual Report Message from the Cancer Committee: On behalf of the Cancer Committee of The Methodist Hospitals, we are pleased to present to you our 2016 Oncology Institute Annual

More information

Cancer in New Mexico 2017

Cancer in New Mexico 2017 Cancer in New Mexico 0 Please contact us! Phone: 0-- E-Mail: nmtr-info@salud.unm.edu URL: nmtrweb.unm.edu TABLE OF CONTENTS Introduction... New Cases of Cancer Estimated Number of New Cancer Cases Description

More information

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina

8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina FIRST ANNOUNCEMENT 8 th InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies' October 17-18, 2019 Buenos Aires, Argentina The 8 th Conference of IAOC "Current

More information

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 25-27, 2017

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC October 25-27, 2017 Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development One Washington Circle Hotel, Washington, DC 20037 October 25-27, 2017 Wednesday, October 25, 2017 7:30 8:30 AM Registration

More information

Cancer in New Mexico 2014

Cancer in New Mexico 2014 Cancer in New Mexico 2014 Please contact us! Phone: 505-272-5541 E-Mail: info@nmtr.unm.edu http://som.unm.edu/nmtr/ TABLE OF CONTENTS Introduction... 1 New Cases of Cancer: Estimated Number of New Cancer

More information

Message from the President & CEO John Solheim, FACHE

Message from the President & CEO John Solheim, FACHE Message from the President & CEO John Solheim, FACHE Welcome to the 8 edition of the St. Peter s Hospital Cancer Program Annual Report. This report describes in detail the incidence of cancer and oncology

More information

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types

2 Diagnosis and Staging of Cancer 2.1 Pathophysiology of cancer 2.2 Classification and staging 2.3 Diagnostic measures for specific cancer types Oncology Nursing Sub-Specialty Module Reference: Gobel B. M., Triest-Robertson S. & Vogel W.H. (Eds). (205). Advanced Oncology Nursing Certificate Review and Resources Manual. Pittsburgh: Oncology Nursing

More information

Exploring the healthcare cost implications of cancer stage. England level modelling

Exploring the healthcare cost implications of cancer stage. England level modelling Exploring the healthcare cost implications of cancer stage England level modelling Rachel White (Rwhite@macmillan.org.uk) Thursday 22 nd September 2016 What we re covering Modelling methods Results - variation

More information

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019 MONDAY, JUNE 3, 2019 7:30 AM - 9:15 AM HIGHLIGHTS OF THE DAY 8:00 AM - 9:00 AM S 8:00 AM - 9:15 AM S S 8:00 AM - 11:00 AM S Highlights of the Day Session II Bringing New and Innovative Glioblastoma Treatments

More information

Trends and disparities in cancer in Aotearoa/ NZ

Trends and disparities in cancer in Aotearoa/ NZ Trends and disparities in cancer in Aotearoa/ NZ Professor Diana Sarfati #cancercrossroads @DiSarfati Why cancer? Estimated number of incident cases from 2018 to 2040 in New Zealand, all cancers, both

More information

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018

Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018 Cancer: Pathophysiology, Current Therapies, Clinical Trials and Drug Development MicroTek Training Center Washington, DC October 17 19, 2018 Wednesday, October 17, 2018 8:00 8:30 AM Registration and Continental

More information

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more

More information

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014 Cancer in Rural Illinois, 1990-2010 Incidence, Mortality, Staging, and Access to Care April 2014 Prepared by Whitney E. Zahnd, MS Research Development Coordinator Center for Clinical Research Southern

More information

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R) Item 18-13c NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May 2013 BREAST CANCER MCN: Breast Disease: Breast Document ready to circulate lead to be discussed

More information

Florida Hospital Cancer Institute

Florida Hospital Cancer Institute REGISTER NOW AT - Official Best of ASCO Meeting A program licensed by the American Society of Clinical Oncology September 15-16, 2018 The Ritz Carlton Orlando, Grande Lakes 4012 Central Florida Parkway

More information

Australian Organisation Launches Large International Clinical Trials in Prostate Cancer

Australian Organisation Launches Large International Clinical Trials in Prostate Cancer Australian Organisation Launches Large International Clinical Trials in Prostate Cancer Media Release Sydney 8 April, 2014: The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.

More information

Epidemiology in Texas 2006 Annual Report. Cancer

Epidemiology in Texas 2006 Annual Report. Cancer Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer

More information

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives 2008 Oncology Pharmacy Preparatory Review Course Learning Objectives Session 1 Symptom Management, Part I, II & III Teresa A. Mays, Pharm D., BCOP Director, Investigational Drug Department San Antonio,

More information

Survey Results Holiday Delivery Services

Survey Results Holiday Delivery Services Survey Results Holiday Delivery Services 13 DELIVERY HOLIDAY COMPARISON: IHLS, RAILS, ILDS, CPL MONTH HOLIDAY IHLS RAILS ILDS CPL July Independence Day September Labor Day October Columbus Day vember Veterans

More information

Nation nal Cancer Institute. Prevalence Projections: The US Experience

Nation nal Cancer Institute. Prevalence Projections: The US Experience Nation nal Cancer Institute Prevalence Projections: The US Experience State of Art Methods for the Analysis of Population- Based Cancer Data January 22-23, 2014 Ispra, Italy U.S. DEPARTMENT OF HEALTH AND

More information

2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives

2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives 2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives Acute Leukemia/Tumor Lysis Syndrome John M. Valgus, Pharm.D., BCOP Hematology/Oncology Specialist University of North

More information

Washington, DC Washington, DC Washington, DC Washington, DC 20510

Washington, DC Washington, DC Washington, DC Washington, DC 20510 March 12, 2018 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman Committee on Appropriations Committee on Appropriations Washington, DC 20510 Washington, DC 20510 The Honorable

More information

Oncology Clinical Program Update. William Sause Medical Director Oncology Clinical Program

Oncology Clinical Program Update. William Sause Medical Director Oncology Clinical Program Oncology Clinical Program Update William Sause Medical Director Oncology Clinical Program Outline Cancer Program Background Screening Quality Care New Technology Contact Information Cancer Cases Utah 2011

More information

Local Cancer Support Groups

Local Cancer Support Groups . Local Cancer s Patient Information Author ID: AA Leaflet Number: CC 029 Version: 6 Name of Leaflet: Local Cancer s Date Produced: July 2018 Review Date: July 2020 Local support groups offer emotional

More information

Trends in Cancer Survival in NSW 1980 to 1996

Trends in Cancer Survival in NSW 1980 to 1996 Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August

More information

USMLE STEP 2 CK REVIEW STUDY GUIDE

USMLE STEP 2 CK REVIEW STUDY GUIDE USMLE STEP 2 CK REVIEW STUDY GUIDE 2014 edition Brian Jenkins, MD Although you have the flexibility to view the videos in any order, we strongly recommend that you watch the videos in the order in which

More information

Multidisciplinary Genitourinary Oncology Course:

Multidisciplinary Genitourinary Oncology Course: Taussig Cancer Institute and Glickman Urological Institute present Multidisciplinary Genitourinary Oncology Course: Focus on Kidney, Bladder, and Testicular Cancer Thursday, December 14, 2017 Cleveland,

More information

Potentially preventable cancers among Alaska Native people

Potentially preventable cancers among Alaska Native people Potentially preventable cancers among Alaska Native people Sarah Nash Cancer Surveillance Director, Alaska Native Tumor Registry Diana Redwood, Ellen Provost Alaska Native Epidemiology Center Cancer is

More information

ONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE

ONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE ASCO 2018 ONCOLOGY AND MALIGNANT HEMATOLOGY REVIEW CONFERENCE September 28, 2018 Eastern Area Health Education Center 2600 W. Arlington Blvd. Jointly provided by: East Carolina University Department of

More information

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry

More information

NATIONAL CANCER CONTROL PROGRAMME NATIONAL STRATEGY FOR THE SAFE ADMINISTATION OF CANCER DRUGS

NATIONAL CANCER CONTROL PROGRAMME NATIONAL STRATEGY FOR THE SAFE ADMINISTATION OF CANCER DRUGS NATIONAL CANCER CONTROL PROGRAMME NATIONAL STRATEGY FOR THE SAFE ADMINISTATION OF CANCER DRUGS Dr Susan O Reilly MB, FRCPC, FRCPI National Director National Cancer Control Programme IMSN Networking for

More information

National Cancer Statistics in Korea, 2014

National Cancer Statistics in Korea, 2014 National Cancer Statistics in Korea, 2014 2016. 12. 20. Korea Central Cancer Registry Cancer Incidence in Korea, 2014 National Cancer Incidence, 2014 Trends in Cancer Incidence by Sex and Year * Dark colored

More information

Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES

Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES 08-04-2017 12:45-13:00 Type: Educational session Title: Welcome and Introduction by the Chairs 1 2 1 2 Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES 12:45-13:00 Welcome 13:00-13:15

More information

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research

Action to Cure Kidney Cancer Campaign to Fund Kidney Cancer Research Action to Cure Kidney Cancer 2016 Campaign to Fund Kidney Cancer Research Kidney Cancer Facts 9 th most common cancer in the U.S. Until recently, 3 rd highest rate of increasing incidence of all cancers

More information

Phase-specific Net Costs of Cancer Care in Ontario. Claire de Oliveira, M.A. PhD

Phase-specific Net Costs of Cancer Care in Ontario. Claire de Oliveira, M.A. PhD Phase-specific Net Costs of Cancer Care in Ontario Claire de Oliveira, M.A. PhD Background Cancer: leading cause of death in Canada with costly implications for government and patients Cost estimates of

More information

Long-term survival rate of stage I-III small cell lung cancer patients in the SEER database - application of the lognormal model

Long-term survival rate of stage I-III small cell lung cancer patients in the SEER database - application of the lognormal model Long-term survival rate of stage I-III small cell lung cancer patients in the SEER database - application of the lognormal model Patricia Tai, MD, (Acting Director of Radiation Oncology), Edward Yu, MD,

More information

COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER

COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER 2015 COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER CANCER COMMITTEE Lowndes Harrison, MD, Radiation Oncology, Cancer Committee Chairman, Cancer Conference Coordinator

More information

Development status of OPDIVO (nivolumab) 1

Development status of OPDIVO (nivolumab) 1 August 1, 2018 Development status of OPDIVO (nivolumab) 1 Target disease JAPAN US/EU KR/TW Melanoma (1 st ) Approved Approved Approved Melanoma (Adjuvant Therapy) Filing Approved (US) Non-small cell lung

More information

Macmillan Publications

Macmillan Publications S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer

More information

PRINCIPLES OF ONCOLOGY FOR CANCER REGISTRY PROFESSIONALS SYLLABUS AND OBJECTIVES

PRINCIPLES OF ONCOLOGY FOR CANCER REGISTRY PROFESSIONALS SYLLABUS AND OBJECTIVES PRINCIPLES OF ONCOLOGY FOR CANCER REGISTRY PROFESSIONALS SYLLABUS AND OBJECTIVES MONDAY 8:00 Introductions and Pre-Training Assessment Objective: to obtain a baseline level of cancer knowledge for the

More information

COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER

COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER 2014 COMMUNITY CANCER PROGRAM ACCREDITATION WITH COMMENDATION BY THE COMMISION ON CANCER CANCER COMMITTEE Lowndes Harrison, MD, Radiation Oncology, Cancer Committee Chairman, Cancer Conference Coordinator

More information

Development Pipeline Progress Status. February 1, 2019

Development Pipeline Progress Status. February 1, 2019 Development Pipeline Progress Status February 1, 2019 /9 Development status of OPDIVO (nivolumab) (1) Target disease JAPAN US/EU KR/TW Melanoma (1 st ) Approved Approved Approved Melanoma (Adjuvant Therapy)

More information

Cancer Annual Report. Our story begins with you.

Cancer Annual Report. Our story begins with you. Cancer Annual Report 17 Our story begins with you. Chairman s message The Cancer Committee is formed under the direction of the Bylaws of the Medical Executive Committee and serves to monitor, supervise

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland

More information

CANCER INCIDENCE AND SURVIVAL STATISTICS FOR NORTHERN IRELAND

CANCER INCIDENCE AND SURVIVAL STATISTICS FOR NORTHERN IRELAND 12 March 2019 CANCER INCIDENCE AND SURVIVAL STATISTICS FOR NORTHERN IRELAND 1993-2017 Official Statistics on cancers diagnosed in Northern Ireland during 1993-2017 were published today. This release provides

More information

Location of cancer services and cancer support services in NEMICS region

Location of cancer services and cancer support services in NEMICS region Location of cancer services and cancer support services in NEMICS region Contents 1. Diagnostics, radiology, pathology, research, and outpatients... 2 2. Multidisciplinary meetings and cancer surgery...

More information

Examining Special Nutritional Requirements in Disease States. Steven K. Clinton, MD, Ph.D.

Examining Special Nutritional Requirements in Disease States. Steven K. Clinton, MD, Ph.D. Examining Special Nutritional Requirements in Disease States. Steven K. Clinton, MD, Ph.D. The Ohio State University Comprehensive Cancer Center 1 Financial Conflicts of Interest None Opinions Many 2 Research

More information

CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018

CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018 CDx in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900 Research unit Versailles Saint-Quentin-en-Yvelines

More information

Test Bank for Understanding Pathophysiology 4th Edition by Huether

Test Bank for Understanding Pathophysiology 4th Edition by Huether Test Bank for Understanding Pathophysiology 4th Edition by Huether Link full download: http://testbankair.com/download/test-bank-for-understandingpathophysiology-4th-edition-by-huether/ Sample Chapter

More information

REPORT American College of Surgeons Approved Program

REPORT American College of Surgeons Approved Program REPORT 9 American College of Surgeons Approved Program Cancer Treatment Center Report 9 Welcome to the 9 edition of the St. Peter s Hospital Cancer Treatment Center Annual Report. This report describes

More information

The Future of the Peer Review Programme

The Future of the Peer Review Programme The Future of the Peer Review Programme The future of the programme has been in some considerable doubt. However thanks to the support of: Sean Duffy National Clinical Lead for Cancer, James Palmer Clinical

More information

PROOF. Advances in Oncology th Annual. September 30 - October 1, 2016 Hyatt Regency Sacramento, CA CONFERENCE DIRECTORS

PROOF. Advances in Oncology th Annual. September 30 - October 1, 2016 Hyatt Regency Sacramento, CA CONFERENCE DIRECTORS 17 th Annual Advances in Oncology 2016 September 30 - October 1, 2016 Hyatt Regency Sacramento, CA (The September 25th conference is held at the Cancer Center Auditorium ) CONFERENCE DIRECTORS Helen K.

More information

Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy

Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy Value of true whole-body FDG- PET/CT scanning protocol in oncology and optimization of its use based on primary malignancy Ronnie Sebro MD, Ph.D Carina Mari Aparici MD, Miguel Hernandez Pampaloni MD, PhD

More information

Samuel M. Lesko, MD, MPH Director of Research/Medical Director

Samuel M. Lesko, MD, MPH Director of Research/Medical Director Cancer in Northeastern Pennsylvania: Incidence, Mortality and Survival for Common Cancers Samuel M. Lesko, MD, MPH Director of Research/Medical Director May 11 334 Jefferson Avenue, Scranton, PA 1851-57-941-7984

More information

Development status of OPDIVO (nivolumab) 1

Development status of OPDIVO (nivolumab) 1 November 2, 2018 Development status of OPDIVO (nivolumab) 1 Target disease JAPAN US/EU KR/TW Melanoma (1 st ) Approved Approved Approved Melanoma (Adjuvant Therapy) Approved Approved(EU) Non-small cell

More information

Cancer in Huron County

Cancer in Huron County Cancer in Huron County 2-29 Prepared by: Erica Clark, Epidemiologist April 214 77722B London Road RR 5, Clinton, ON NM 1L 519.482.3416 F: 519.482.782 www.huronhealthunit.com Cancer Health Status Report

More information

Targeting the Oncogenic Pathway as Opposed to the Primary Tumor Site: HER2 as an Example

Targeting the Oncogenic Pathway as Opposed to the Primary Tumor Site: HER2 as an Example Targeting the Oncogenic Pathway as Opposed to the Primary Tumor Site: HER2 as an Example Dennis J Slamon, MD, PhD Professor of Medicine Chief, Division of Hematology/Oncology; Director of Clinical/Translational

More information

Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC)

Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Smoking and Mortality SECTION 6 Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Kotaro Ozasa Abstract In the JACC study, risk of death with all cancers and

More information

dedicated to curing cancer today. cancercarewny.com

dedicated to curing cancer today. cancercarewny.com dedicated to curing cancer today. cancercarewny.com our team Radiation Oncology Michael Duff, M.D. is a board-certified radiation oncologist and graduate of the SUNY at Buffalo School of Medicine. He completed

More information

Overview of All SEER-Medicare Publications

Overview of All SEER-Medicare Publications Overview of All SEER-Medicare Publications Outcomes Insights, Inc. Mark D. Danese, MHS, PhD Claire Cangialose February 22, 2017 Overview Information was extracted from the National Cancer Institute (NCI)

More information

Bleeding Rates and Risk Factors among Cancer and Non-Cancer Patients: A Comparison of Several Anticoagulants

Bleeding Rates and Risk Factors among Cancer and Non-Cancer Patients: A Comparison of Several Anticoagulants Bleeding Rates and Risk Factors among Cancer and Non-Cancer Patients: A Comparison of Several Anticoagulants Dana E. Angelini, MD 1, Tomas Radivoyevitch, PhD 2, Keith McCrae, MD 1, Alok A. Khorana, MD,

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

The reality of cancer clinical trials in Latin America

The reality of cancer clinical trials in Latin America The reality of cancer clinical trials in Latin America Gustavo Werutsky Latin American Cooperative Oncology Group (LACOG) 18 April 2018, Mexico City, Mexico None Conflicts of Interest Cancer in Latin America

More information

Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program

Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program Joxel Garcia, MD, MBA Executive Director, Cancer Prevention and Control Platform Member, Moon Shots Program Leadership Team The

More information

Identifying and counting people living with treatable but not curable cancer

Identifying and counting people living with treatable but not curable cancer Identifying and counting people living with treatable but not curable cancer Rachel White Joanna Pethick, Archie Macnair, Gregory Fallica, Jennifer Than and Jane Maher September 2018 Who are the people

More information

Cancer survival in Hong Kong SAR, China,

Cancer survival in Hong Kong SAR, China, Chapter 5 Cancer survival in Hong Kong SAR, China, 1996 2001 Law SC and Mang OW Abstract The Hong Kong cancer registry was established in 1963, and cancer registration is done by passive and active methods.

More information

Managing Older Patients With Lymphoma and Multiple Myeloma

Managing Older Patients With Lymphoma and Multiple Myeloma 2006 ONS Congress Webcast Evaluation Form Managing Older Patients With Lymphoma and Multiple Myeloma Session length: 1 hour, 45 minutes Contact hours: 1.5 Pharmacology hours offered: 15 minutes How to

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2014 334 Jefferson Avenue, Scranton,

More information

International Agency for Research on Cancer Lyon, France

International Agency for Research on Cancer Lyon, France Global Burden of Cancer in Attributable to Alcohol Consumption International Agency for Research on Cancer Lyon, France Kevin D Shield (Shieldk@fellow.iarc.fr), Pietro Ferrari, Jacques Ferlay, Freddie

More information

Radiation Oncology Study Guide

Radiation Oncology Study Guide Radiation Oncology Study Guide For the Initial CertificationQualifying (Computer-Based) Examination General and Radiation Oncology This examination is designed to assess your understanding of the entire

More information

Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression. Tuesday 17 th September 2013

Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression. Tuesday 17 th September 2013 Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression Tuesday 17 th September 2013 Welcome, Introduction and Aims of the Event Dr Tom Newsom-Davis, LCA AOS Pathway Chair Why MSCC?

More information

CANCER FACTS & FIGURES For African Americans

CANCER FACTS & FIGURES For African Americans CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5

More information

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013

LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 LANDMARK MEDICAL CENTER CANCER PROGRAM YEAR IN REVIEW 2013 Landmark Medical Center offers a comprehensive cancer care services to our patients. LMC Cancer program is committed to ensure that patients receive

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Acuna SA, Fernandes KA, Daly C, et al. Cancer mortality among recipients of solidorgan transplantation in Ontario, Canada. JAMA Oncol. Published online January 7, 2016. doi:10.1001/jamaoncol.2015.5137

More information

55 th Annual Meeting American Society for Radiation Oncology. Patients: Hope Guide Heal News Briefing

55 th Annual Meeting American Society for Radiation Oncology. Patients: Hope Guide Heal News Briefing 55 th Annual Meeting American Society for Radiation Oncology Patients: Hope Guide Heal News Briefing Sunday, September 22, 2013 4:45 p.m. 5:15 p.m. Colleen A.F. Lawton, MD, FASTRO 2013 ASTRO President

More information

National Cancer Institute

National Cancer Institute Patient- reported outcome surveillance in older cancer survivors: Using the SEER-MHOS linked data resource Erin E. Kent, PhD Epidemiologist & Program Director Outcomes Research Branch Applied Research

More information

La Corte está cerrada el lunes, 17 de enero de 2011, el Día de Martin Luther King Jr.

La Corte está cerrada el lunes, 17 de enero de 2011, el Día de Martin Luther King Jr. Monday, January 17, 2011 for Martin Luther King Jr. Day. 17 de enero de 2011, el Día de Martin Luther King Jr. Poster by Transcend, 2011. File available at: www.transcend.net/library.htm Friday, February

More information

Duke at. American Society of Clinical Oncology Chicago, Illinois

Duke at. American Society of Clinical Oncology Chicago, Illinois Duke at American Society of Clinical Oncology 2017 Chicago, Illinois Duke Medicine Divisions of Hematology Medical Oncology and Hematologic Malignancy & Cellular Therapy Cordially invite you to the Duke

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator December 2017 334 Jefferson Avenue, Scranton,

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2018 334 Jefferson Avenue, Scranton,

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland

More information

Monitoring Patients Undergoing Cancer Therapy. By Timothy K. Egan

Monitoring Patients Undergoing Cancer Therapy. By Timothy K. Egan F E A T U R E By Timothy K. Egan Before placement in a computed tomography scanner, a patient is fitted with an immobilization device. Immobilization ensures that the same area of the patient is scanned

More information

Cancers Associated With BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian

Cancers Associated With BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian Cancers Associated With BRCA1 and BRCA2 Mutations Other Than Breast and Ovarian Jacqueline Mersch, MS, CGC 1 ; Michelle A. Jackson, MS, CGC 2 ; Minjeong Park, PhD 3 ; Denise Nebgen, MD, PhD 4 ; Susan K.

More information

SKCC Protocol Review Committee New Study Application

SKCC Protocol Review Committee New Study Application Instructions: Submit the following documents to prc@jefferson.edu - Completed New Study Application (aka MCSF) - Protocol - Protocol Facilitation Committee Approval (if applicable) - MDG Priority Score

More information